News | January 8, 2021
DiCE gets its ‘library’ card ready as it speeds development of DNA database-derived molecules with more investor cash
Read More
News | January 7, 2021
CARISMA Therapeutics Completes Series B Funding to Advance Development of Novel CAR-Macrophage Immunotherapies
Read More
Press Release | December 21, 2020
Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
Read More
News | November 20, 2020
Lilly, Precision Biosciences team up on Duchenne gene therapy in $135M deal
Read More
Press Release | November 5, 2020
Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation at 62nd American Society of Hematology Annual Meeting
Read More
News | November 3, 2020
Orbus Therapeutics Publishes in Oncotarget Scientific Journal
Read More
Press Release | October 22, 2020
Orbus Therapeutics Expands Series A Financing to $71 Million to Support Ongoing STELLAR Phase 3 Study in Rare Brain Cancer
Read More
Press Release | October 19, 2020
Aptinyx Reports Positive, Statistically Significant, Top-line Data From Phase 2 Study of NYX-783 in Patients With Post-Traumatic Stress Disorder
Read More
Press Release | October 15, 2020
Precision BioSciences Announces U.S. Patent Trial and Appeal Board Upholds Allogeneic CAR T Patents
Read More
Press Release | October 14, 2020
ImCheck Announces Four ICT01 Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting
Read More
Press Release | October 9, 2020
Geeta Vemuri named Top 100 Powerful Women of 2020 by Entrepreneur
Read More
News | October 1, 2020
Skyhawk Therapeutics Named Top 11 Biotech Startup 2020 by Endpoints News
Read More
Press Release | September 17, 2020
Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors
Read More
Press Release | September 10, 2020
ImCheck Achieves Initial Positive Independent Safety Review and Initiates Next Stage of Phase I/IIa EVICTION Trial for ICT01. Company Receives FDA Approval for US IND
Read More
News | August 26, 2020
Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection
Read More
News | August 17, 2020
BMS Licenses IL-12 from Dragonfly in $475 Million Upfront Deal
Read More
News | July 29, 2020
Women in Bio: Geeta Vemuri Blazes a Trail in Venture Capital
Read More
Press Release | July 27, 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
Read More
News | July 23, 2020
Clearing the Hurdles to a Career in Venture Capital; An Interview with Geeta Vemuri
Read More
Press Release | July 16, 2020
Agent Capital Expands Management Team; Appoints Jacopo Leonardi as Partner
Read More
